Evidence map›Paper›PMID 39634654›Full record

ArticleFrontiers in aging neuroscience2024

Skeletal muscle proteome differs between young

Chelsea N Johnson, Colton R Lysaker, Colin S McCoin, Mara R Evans, John P Thyfault, Heather M Wilkins, Jill K Morris, Paige C Geiger

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. iScience · 2026
    Article
  2. Exploratory associations between APOE-εFrontiers in neurology · 2026
    Article
  3. Proteomic and metabolic profiling revealsbioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chelsea N JohnsonDepartment of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, MO, United States.
Colton R LysakerUniversity of Kansas Alzheimer's Disease Center, University of Kansas Medical Center, Fairway, KS, United States.
Colin S McCoinDepartment of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, MO, United States.
Mara R EvansDepartment of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, MO, United States.
John P ThyfaultDepartment of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, MO, United States.
Heather M WilkinsUniversity of Kansas Alzheimer's Disease Center, University of Kansas Medical Center, Fairway, KS, United States.
Jill K Morris *University of Kansas Alzheimer's Disease Center, University of Kansas Medical Center, Fairway, KS, United States.
Paige C Geiger *Department of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, MO, United States.

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Douglas E Wright · 2012 to 2026
$63.0M
Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ROY A. JENSEN · 2012 to 2026
$40.1M
University of Kansas Alzheimer's Disease Research Center (KU ADRC)P30AG072973 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Mohammad Haeri · 2021 to 2026
$25.3M
Supplement for Google cloud build-outR24GM137786 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Alan Tackett · 2020 to 2026
$15.4M
longitudinal assessment of stress and stress-related concepts across a behavioral weight loss interventionP20GM144269 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI John P Thyfault, STEVEN A WEINMAN · 2022 to 2026
$14.9M
Multidisciplinary Research Training Program in Alzheimer's Disease and Related DisordersT32AG078114 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Sandra A Billinger, Eric Dennis Vidoni · 2022 to 2026
$1.2M
Metabolic Phenotyping ClusterS10OD028598 · OD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI THYFAULT, JOHN P · 2020 to 2020
$602k
Skeletal muscle mitochondrial abnormalities in Alzheimer's DiseaseR21AG056062 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI THYFAULT, JOHN P · 2017 to 2018
$421k
NCI NIH HHS P30 CA168524NIA NIH HHS P30 AG072973NIA NIH HHS R21 AG056062NIA NIH HHS T32 AG078114NIGMS NIH HHS P20 GM103418NIGMS NIH HHS P20 GM144269NIGMS NIH HHS R24 GM137786NIH HHS S10 OD028598
6 · The paper itself

Abstract

Introduction: Apolipoprotein E4 ( Methods: Here, we sought to determine the impact of Results: We found that Discussion: This work highlights early involvement of skeletal muscle in a mouse model of

Indexed as

Alzheimer's diseaseAPOE4micemitochondriaproteomicsskeletal muscle

Identifiers

PMID39634654
PMCPMC11615480

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.